Energy supercomplex promises better options for heart disease treatment
A novel mechanism that enables cells to maintain energy production even when their main power supply drops/fails has been ...
thecardiologyadvisor.com6 天
FDA Extends Review of Elamipretide for Barth Syndrome
The FDA has extended the review period for the New Drug Application for elamipretide for the treatment of Barth syndrome.